When the cohorts of astrocytoma and oligodendroglioma were combined as ‘LGG’, expectedly, because of the different OS of each of the subtypes, no significant prognostic effect of TP53 mutation was observed (p = 0.917) (Supplementary File 2: Figure S1C). This evidence concerns the gene TP53 and oligodendroglioma.